Follow the Funding, May 2017

Introducing a new monthly feature focused on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.

TargetInvestorsAmountDate
Catalia HealthKhosla Ventures$2.5 million seed extension roundMay 1, 2017
ReThink MedicalEmergent Medical Partners, Norwich Ventures and Launch Capital$3 million Series AMay 1, 2017
Teewinot Life Sciences CorporationTuatara Capital$12.3 million Series BMay 1, 2017
TetraGeneticsJDRF T1 FundNot disclosedMay 2, 2017
Lantern PharmaBios Partners, GPG Ventures and others$3.7 million Series AMay 2, 2017
ExoCoBio Inc. SBI InvestmentSBI Investment, Atinum Investment, ID Ventures and Dt&Investment$11 million Series AMay 3, 2017
EverlyWellNextGen Venture Partners, Jack Novak, SoGal Ventures, Full Tilt Capital and others$2.5 millionMay 3, 2017
Vivet TherapeuticsNovartis Venture Fund, Columbus Venture Partners, Roche Venture Fund, HealthCap, Kurma Partners and Ysios CapitalUSD$40,981,874 (€37.5 million) Series AMay 4, 2017
PreparedHealtPreparedHealthhChicago Ventures, Pritzker Group Venture Capital, Beverly Capital and Meridian Street Capital$4 million seed fundingMay 4, 2017
Artemis HealthMaverick Ventures$8.3 millionMay 8, 2017
Advanced Medical Pricing Solutions, Inc.Cimarron Healthcare Capital, RAF Industries and Leavitt Equity PartnersRecapMay 10, 2017
Genoa PharmaceuticalsF-Prime Capital Partners and Edmond de Rothschild Investment Partners.$62 million Series AMay 15, 2017
Highland Capital Management Korea Ltd. healthcare fundSouth Korea's National Pension Service, anchor investor$147 millionMay 14, 2017
Upfront Healthcare ServicesNashville Capital Network, with Echo Health Ventures, Hyde Park Venture Partners and Martin Ventures$5.6 millionMay 17, 2017
VericredFCA Venture Partners$5.5 million Series AMay 18, 2017
Lemonaid HealthNovartis Venture Fund and Himka Ventures, with Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures$11 million Series AMay 22, 2017
Anaconda BiomedYsios Capital, Omega Funds, Banco Sadabell and Innogest Capital€15 million Series AMay 22, 2017
Hound Labs, Inc. Benchmark Capital$8.1 millionMay 23, 2017
CANbridge Life SciencesLapam Capital, with Qiming Venture Partners, Yuanming Capital, Yanyuan Capital, Biossom Investment Management and Wuxi App Tec.$25 millionMay 23, 2017
TP TherapeuticsOrbiMed$45 million Series CMay 23, 2017
Harpoon TherapeuticsArix Bioscience and New Leaf Venture Partners, with Taiho Ventures and MPM Capital$45 million Series BMay 25, 2017
VizAlphabet's Innovation Endeavors, DHVC, AME Cloud Ventures and Susa Ventures$4.7 million first roundMay 25, 2017
MedrioQuesta Capital Management$30 millionMay 25, 2017

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *